These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 33204428)

  • 1. Use of convalescent plasma therapy in eight individuals with mild COVID-19.
    Ji F; Liu W; Hao DA; Cheng J; Tong XC; Hao JG; Wang LP; Li CY; Dai MJ; Yan XB
    New Microbes New Infect; 2021 Jan; 39():100814. PubMed ID: 33204428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convalescent plasma appears efficacious and safe in COVID-19.
    Khulood D; Adil MS; Sultana R; Nimra
    Ther Adv Infect Dis; 2020; 7():2049936120957931. PubMed ID: 33062267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial.
    Franchini M; Glingani C; Morandi M; Corghi G; Cerzosimo S; Beduzzi G; Storti A; Di Stasi V; Rastrelli G; Vignozzi L; Mengoli C; Garuti M; Beccaria M; Inglese F; Caruso B; Petilino RA; Amato M; Nicchio M; Pagani M; Bellani A; Castelli G; Casari S; De Donno G
    Mayo Clin Proc Innov Qual Outcomes; 2021 Apr; 5(2):403-412. PubMed ID: 33585799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
    Beaudoin-Bussières G; Laumaea A; Anand SP; Prévost J; Gasser R; Goyette G; Medjahed H; Perreault J; Tremblay T; Lewin A; Gokool L; Morrisseau C; Bégin P; Tremblay C; Martel-Laferrière V; Kaufmann DE; Richard J; Bazin R; Finzi A
    mBio; 2020 Oct; 11(5):. PubMed ID: 33067385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis.
    Barreira DF; Lourenço RA; Calisto R; Moreira-Gonçalves D; Santos LL; Videira PA
    Front Med (Lausanne); 2021; 8():660688. PubMed ID: 33889590
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy.
    Moniuszko-Malinowska A; Czupryna P; Boczkowska-Radziwon B; Wasiluk T; Borawski K; Dunaj J; Bujno M; Radziwon P; Rutkowski K; Pancewicz S
    Am J Case Rep; 2020 Sep; 21():e927662. PubMed ID: 32991573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefits and Risks.
    Noor R; Tasnim N; Saha C
    Curr Clin Microbiol Rep; 2021; 8(3):194-198. PubMed ID: 34249604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases.
    Thijssen M; Devos T; Ejtahed HS; Amini-Bavil-Olyaee S; Pourfathollah AA; Pourkarim MR
    Microorganisms; 2020 Nov; 8(11):. PubMed ID: 33167389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience.
    Joyner MJ; Senefeld JW; Klassen SA; Mills JR; Johnson PW; Theel ES; Wiggins CC; Bruno KA; Klompas AM; Lesser ER; Kunze KL; Sexton MA; Diaz Soto JC; Baker SE; Shepherd JRA; van Helmond N; van Buskirk CM; Winters JL; Stubbs JR; Rea RF; Hodge DO; Herasevich V; Whelan ER; Clayburn AJ; Larson KF; Ripoll JG; Andersen KJ; Buras MR; Vogt MNP; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Paneth NS; Fairweather D; Wright RS; Carter RE; Casadevall A
    medRxiv; 2020 Aug; ():. PubMed ID: 32817978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convalescent Blood Products in COVID-19: A Narrative Review.
    Chua Vi Long K; Sayed A; Karki P; Acharya Y
    Ther Adv Infect Dis; 2020; 7():2049936120960646. PubMed ID: 33014364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of convalescent plasma therapy in a patient with severe COVID-19-associated acute kidney injury.
    Brener ZZ; Brenner A
    Clin Nephrol Case Stud; 2021; 9():67-71. PubMed ID: 34084692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convalescent Plasma Therapy and Its Effects On COVID-19 Patient Outcomes: A Systematic Review of Current Literature.
    Bakhtawar N; Usman M; Khan MMU
    Cureus; 2020 Aug; 12(8):e9535. PubMed ID: 32905148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection.
    Zhu H; Fu L; Jin Y; Shao J; Zhang S; Zheng N; Fan L; Yu Z; Ying J; Hu Y; Chen T; Chen Y; Chen M; Chen M; Xiong Z; Kang J; Jin J; Cai T; Ye H
    J Clin Lab Anal; 2020 Jul; 34(7):e23392. PubMed ID: 32506726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Convalescent Plasma Therapy for COVID-19 Patients in Hunan, China.
    Hu X; Hu C; Jiang D; Zuo Q; Li Y; Wang Y; Chen X
    Dose Response; 2020; 18(4):1559325820979921. PubMed ID: 33402882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of convalescent plasma therapy on novel coronavirus infection].
    Zhao Q; He Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 May; 43(5):409-413. PubMed ID: 32450629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study.
    Albalawi M; Zaidi SZA; AlShehry N; AlAskar A; Zaidi ARZ; Abdallah RNM; Salam A; AlSagheir A; AlMozain N; Elgohary G; Batarfi K; Alfaraedi A; Khojah O; Al-Ansari R; Alfaraj M; Dayel A; Al Bahrani A; Abdelhameed AN; Alhumaidan H; Al-Otaibi JM; Radwi G; Raizah A; Shatry H; Alsaleh S; AlZahrani H; Al-Hashmi H
    JMIR Res Protoc; 2020 Oct; 9(10):e23543. PubMed ID: 32903199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates.
    Verma HK; Farran B; Bhaskar LVKS
    Antib Ther; 2020 Apr; 3(2):115-125. PubMed ID: 33912791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.
    Yin S; Peng Y; Ren Y; Hu M; Tang L; Xiang Z; Li X; Wang M; Wang W
    J Clin Virol; 2020 Jul; 128():104397. PubMed ID: 32388472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.